DRUG ABUSE LIABILITY SHOULD BE ASSESSED BY END OF PHASE II -- FDA's HARTER; ABUSE TREATMENT DEVELOPMENT DRAFT GUIDELINES MAY BE READY BY SEPTEMBER

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".